Journal Guide

Conference proceedings are accepted for publication in Procedia in Vaccinology based on suitability and are required to meet certain criteria, including relevance to an international audience and covering highly cited or timely topics. Procedia in Vaccinology will cover proceedings in all topics related to vaccines and vaccination.

What does Procedia in Vaccinology offer authors and conferences organizers?
Procedia in Vaccinology offers a single, highly recognized platform where conference papers can be hosted and accessed by millions of researchers. Authors then know where to go to keep abreast of the latest developments in their field. All proceedings appear online, on Science Direct, within 8 weeks of acceptance of the final manuscripts via the conference organizer and are freely available to all users. Procedia in Vaccinology offers authors and conference organizers a fast and cost effective way to provide maximum exposure for their papers.

Word templates are provided to assist in the publication and the final online papers contain linked references, XML versions and DOI numbers.

Why should conference organizers choose Procedia in Vaccinology?
Unlike regular journals, there is no limit to the amount of papers a Procedia in Vaccinology issue can contain and pricing is affordable, clear and transparent. Procedia in Vaccinology offers immediate access for all, with papers online within 8 weeks of acceptance, and free access providing maximum exposure for individual papers and the related conference. Organizers are credited on the actual issue and are fully responsible for quality control, the review process and the content of individual conference papers.

What is the process for submitting conference proceedings to Procedia in Vaccinology?
Proposals, including a synopsis of why such a Procedia in Vaccinology issue will have an impact on its community, a list of agreed contributors and an outline of the related conference (including a link to the conference website) should be sent to:

Alina Helsloot
Executive Publisher
a.helsloot@elsevier.com

Proposals should be prepared using the template /inca/publications/misc/PROVAC Proposal Template.dochere.

Please note that we do not accept proposals from individual authors for Procedia titles.

What are the costs associated with Procedia in Vaccinology?
There is an agreed fee, based on the size of the proceedings, which includes online publication on http://www.sciencedirect.comScienceDirect and free access after acceptance. In addition to the online version there is the possibility to purchase paper copies, CD-ROMs and USB sticks. Moreover, interactive media possibilities such as webcasts and web seminars can be acquired for extra exposure both before and after the conference.

Can Procedia in Vaccinology be sponsored?
We are open to discussing sponsoring possibilities at all times. Sponsors can include funding bodies, government agencies and/or industry. Benefits to sponsors include visibility amongst a scientific audience and the opportunity to communicate messages via a peer-reviewed platform. Benefits to authors and conference organizers are the further dissemination of material to an international audience and reduced costs to the overall conference budget.

Progress in Neuro-Psychopharmacology & Biological Psychiatry does not publish work on the actions of biological extracts unless the pharmacological active molecular substrate and/or specific receptor binding properties of the extract compounds are elucidated.

Benefits to authors
We also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our http://www.elsevier.com/wps/find/authorsview.authors/authorservices author services .

Please see our http://www.elsevier.com/wps/find/journaldescription.cws_home/525488/authorinstructionsGuide for Authors for information on article submission. If you require any further information or help, please visit our support pages: http://support.elsevier.com

Prostaglandins & Other Lipid Mediators is the original and foremost journal dealing with prostaglandins and related lipid mediator substances. It includes basic and clinical studies related to the pharmacology, physiology, pathology and biochemistry of lipid mediators.Please bookmark this URL: http://www.elsevier.com/locate/prostaglandinsUS National Institutes of Health (NIH) voluntary posting ("Public Access") policyProstaglandins & Other Lipid Mediators and Elsevier facilitate the author's response to the NIH Public Access Policy. For more details please see the Guide for authorsBenefits to authorsWe also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services .Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our support pages: http://support.elsevier.com

Protein & Cell publishes original research articles, reviews, and commentaries concerning the latest developments in multidisciplinary areas in biology and biomedicine, with an emphasis on protein and cell research. Subject areas include biochemistry/biophysics, cell biology, developmental biology, genetics, immunology, microbiology, molecular biology, neuroscience, oncology, protein science, structural biology and translational medicine. In addition, Protein & Cell addresses research highlights, news and views, and commentaries covering research policies and funding trends in China, and provides a forum to foster academic exchange among researchers across different fields of the life sciences.

Protein & Peptide Letters publishes letters, original research papers, mini-reviews and guest edited issues in all important aspects of protein and peptide research, including structural studies, advances in recombinant expression, function, synthesis, enzymology, immunology, molecular modeling, and drug design. Manuscripts must have a significant element of novelty, timeliness and urgency that merit rapid publication. Reports of crystallization and preliminary structure determination of biologically important proteins are considered only if they include significant new approaches or deal with proteins of immediate importance, and preliminary structure determinations of biologically important proteins. Purely theoretical/review papers should provide new insight into the principles of protein/peptide structure and function. Manuscripts describing computational work should include some experimental data to provide confirmation of the results of calculations

Bring the most current psychopharmacologic and therapeutic neuromodulation interventions to the expert management of your practice. Psychopharm Review offers the most essential, practical advice for recognizing and treating virtually all types of psychiatric disorders. With Psychopharm Review you will:Make well-informed decisions to address neurocognitive effects of medications in elderly patients, treatment of bipolar disorder, and the hazards of inappropriately prescribed medications.Stay current on neuromodulation therapies such as vagus nerve stimulation (VNS), transcranial magnetic stimulation (TMS), and deep brain stimulation (DBS).Fully understand the key issues that can affect your patients' mental health, how to achieve more consistent treatment adherence, and how to approach ethical issues surrounding various therapies.Receive critical reviews of groundbreaking medication trials, such as CATIE and STAR*D.Psychopharm Review understands the demands of daily practice and provides you with practical treatment strategies.

Psychopharmacology is an international journal that covers the broad topic of elucidating mechanisms by which drugs affect behavior. The scope of the journal extends from clinical psychopharmacology, including trials, to experimental studies on the effects of drugs on cognition and behavior in humans and laboratory studies in experimental animals. The research methodologies covered range from neurochemical assays and electrophysiological recording to studies of functional neuroimaging, and the methods of experimental psychology and ethology, as well as clinical neurology and psychiatry.

At the heart of open access for the global chemistry community. RSC Advances publishes advances in chemistry, and in topics of interest to the chemistry community.

RSC Chemical Biology is a gold open access journal dedicated to publishing and disseminating exceptional, breakthrough research and high-quality reviews at the interface of chemistry and biology. We welcome contributions from across the breadth of the chemical biology field. This includes Sensing and Imaging, Bioorthogonal chemistry, Biosynthesis, Biomimetics and Bioengineering, Synthetic biology, Directed evolution, Drugs development and mechanism of action, Glycoscience, Natural products, Nucleic acids, Peptides, Phenotypic screening, Proteins (including protein-protein interactions, modifications, structure and function) We are particularly interested in reports on the application of chemical tools to probe, explore and visualize biological systems and processes to provide insights into molecular mechanisms in health and disease. We also encourage translational research that bridges chemistry and chemical biology to medicine.

RSC Medicinal Chemistry publishes significant research in medicinal chemistry and related drug discovery science. Research articles published in RSC Medicinal Chemistry must show a breakthrough or significant advance on previously published work, or bring new thinking or results that will have a strong impact in their field. Topics within the journal's scope include, but are not limited to: design, synthesis and biological evaluation of novel chemical entities or biotherapeutic modalities; modifications of known chemical entities or biotherapeutic modalities that result in a significantly greater understanding of their structure-activity relationships, an improvement of their properties or provide other information of significant value; novel methodologies and technologies in the broader chemical and biological sciences; computational, machine learning and artificial intelligence (AI) studies are welcome where they significantly advance medicinal chemistry knowledge; studies that examine the effect of the molecular structure of a compound on pharmacokinetic behaviour and pharmacodynamics; studies that present new insights into drug design based on analysis of existing experimental datasets or new theoretical approaches if supported by experimental evidence; studies presenting new drug delivery systems with novel chemical agents are welcomed, in particular those that involve chemical modification of the delivery system of conjugation with novel delivery vectors.

RSC Pharmaceutics is a new gold open access journal leading the way in the field of Pharmaceutics. This journal publishes research focused on formulating a drug into a medicine, with the intention of achieving controllable drug delivery with high efficacy. Research published in RSC Pharmaceutics promotes step-change science in the field of Pharmaceutics, and, as such, all submissions must show clear innovation, be scientifically sound, and have a significant impact on the field. Research sharing new scientific findings from across the areas of chemistry, materials science, biomedical sciences, pharmaceutics and drug delivery are all welcomed. Topics include but are not limited to: • Formulation and design of medicines • Design and characterization of correct dosage forms • Physicochemical and biological properties of drugs and their carriers • Drug delivery devices and their mechanisms of release

Recent Patents on Anti-Cancer Drug Discovery publishes review/mini review and research articles that reflect or deal with studies in relation to a patent, application of reported patents in a study, discussion of comparison of results regarding application of a given patent, etc., and also guest edited thematic issues on recent patents in the field of anti-cancer drug discovery e.g. on novel bioactive compounds, analogs, targets & predictive biomarkers & drug efficacy biomarkers. The journal also publishes book reviews of eBooks and books on anti-cancer drug discovery. A selection of important and recent patents on anti-cancer drug discovery is also included in the journal. The journal is essential reading for all researchers involved in anti-cancer drug design and discovery. The journal also covers recent research (where patents have been registered) in fast emerging therapeutic areas/targets & therapeutic agents related to anti-cancer drug discovery.

Recent Patents on Anti-Infective Drug Discovery publishes review and research articles, drug clinical trial studies and guest edited thematic issues on recent patents in the field of anti-infective drug discovery e.g. on novel bioactive compounds, analogs & targets. A selection of important and recent patents on anti-infective drug discovery is also included in the journal. The journal is essential reading for all researchers involved in anti-infective drug design and discovery. The journal also covers recent research (where patents have been registered) in fast emerging therapeutic areas/targets & therapeutic agents related to anti-infective drug discovery.

Recent Patents on Drug Delivery & Formulation publishes editorials, full-length research articles, short technical notes and guest-edited issues from the academia, industry, and regulatory agencies worldwide, and reviews and mini-reviews with a sharper focus on selected recent patents and patent applications. The journal’s scope covers topics related to preformulation, formulation development, manufacturing technologies, biopharmaceutics, and regulatory science, which include but are not limited to, pharmaceutical nanotechnology, quality by design and process analytical technology, biosimilars and biowaivers, simulation modeling, and intellectual property. Journal’s ambition is to serve as a bridge between academia and industry to stimulate the development of innovative technologies and products for various applications in the field of pharmaceutical and biotechnology sciences.

Recent Patents on Inflammation & Allergy Drug Discovery publishes full-length/mini reviews and research articles that reflect or deal with studies in relation to a patent, application of reported patents in a study, discussion of comparison of results regarding application of a given patent, etc., and also guest edited thematic issues on recent patents in the field of inflammation and allergy drug discovery e.g. on novel bioactive compounds, analogs and targets. A selection of important and recent patents in the field is also included in the journal. The journal is essential reading for all researchers involved in inflammation and allergy drug design and discovery. The journal also covers recent research (where patents have been registered) in fast emerging therapeutic areas/targets & therapeutic agents related to inflammation and allergy drug discovery.

Regulatory Toxicology and Pharmacology, Official Journal of the International Society for Regulatory Toxicology and Pharmacology, reports the concepts and problems involved with the generation, evaluation, and interpretation of experimental animal and human data in the larger perspective of the societal considerations of protecting human health and the environment. The journal is devoted to reports of significant developments, public opinion, scientific data, and ideas that bridge the gap between scientific information and the legal aspects of toxicological and pharmacological regulations.The journal presents articles concerned with regulatory decisions and with the interpretation of scientific knowledge as influencing regulatory decisions. It is addressed to an International readership of scientists, program managers, research directors, attorneys, and business professionals.Benefits to authorsWe also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services .Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our support pages: http://support.elsevier.com

Drawing from a large number of disciplines, Reproductive Toxicology publishes timely, original research on the influence of chemical and physical agents on reproduction. Written by and for obstetricians, pediatricians, embryologists, teratologists, geneticists, toxicologists, andrologists, and others interested in detecting potential reproductive hazards, the journal is a forum for communication among researchers and practitioners. Articles focus on the application of in vitro, animal and clinical research to the practice of clinical medicine.All aspects of reproduction are within the scope of Reproductive Toxicology, including the formation and maturation of male and female gametes, sexual function, the events surrounding the fusion of gametes and the development of the fertilized ovum, nourishment and transport of the conceptus within the genital tract, implantation, embryogenesis, intrauterine growth, placentation and placental function, parturition, lactation and neonatal survival. Adverse reproductive effects in males will be considered as significant as adverse effects occurring in females. To provide a balanced presentation of approaches, equal emphasis will be given to clinical and animal or in vitro work. Typical end points that will be studied by contributors include infertility, sexual dysfunction, spontaneous abortion, malformations, abnormal histogenesis, stillbirth, intrauterine growth retardation, prematurity, behavioral abnormalities, and perinatal mortality.In addition to original research articles, Reproductive Toxicology also publishes interpretative review articles, editorials, letters, book reviews, and conference announcements. The first section of each issue of the journal is devoted to an in-depth, timely review of research on the effect of particular chemical or physical agents on reproduction. Potential authors are encouraged to contact the Editor-in-Chief before submitting such a review.